Effect of Gender on Coagulation Functions: A Study in Metastatic Colorectal Cancer Patients Treated with Bevacizumab, Irinotecan, 5-Fluorouracil, and Leucovorin
Introduction. We designed this study to evaluate how coagulation parameters are changed in metastatic colorectal cancer (mCRC) patients treated with bevacizumab, irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI). Methods. A total of 48 mCRC patients who initially received bevacizumab with FOLFIRI...
Saved in:
| Main Authors: | Cemil Bilir, Hüseyin Engin, Yasemin Bakkal Temi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2014/473482 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liposomal irinotecan with fluorouracil and leucovorin as salvage treatment for advanced biliary tract cancer refractory to gemcitabine and cisplatin
by: Hyunho Kim, et al.
Published: (2025-08-01) -
Phase 1 trial of HR070803 (an Irinotecan liposome) in combination with 5-fluorouracil, leucovorin, and oxaliplatin for untreated advanced or metastatic pancreatic ductal adenocarcinoma
by: Qiang Xu, et al.
Published: (2025-07-01) -
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer
by: Satoshi Kobayashi, et al.
Published: (2025-06-01) -
Acute Myocardial Infarction Caused by Filgrastim: A Case Report
by: Cemil Bilir, et al.
Published: (2012-01-01) -
Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany
by: S. Lonardi, et al.
Published: (2025-09-01)